The call ran from 10:57 AM to 11:54 AM IST (56 min).
Key takeaways
Q2 revenue of ₹51.15 Cr (+12% YoY) and a narrower loss, but US capsule demand is absent, HPMC guidance is dropped, and FY27 API revenue guidance is cut to ₹12-15 Cr.
| Revenue growth | Consolidated Q2 revenue +12% YoY, +5% QoQ; gelatin volumes drove growth. |
|---|---|
| Margins | Habitat 5.88%, up 781bps YoY, 358bps QoQ; API still negative. |
| Demand visibility | US capsule demand absent; gelatin demand firm, several new customers added. |
| Management confidence | Balanced to defensive: admitted HPMC and FY27 API targets missed. |
Growth
Consolidated revenue +12% YoY, +5% QoQ, driven by gelatin conversion of idle HPMC lines, not US demand.
Outlook
FY27 API revenue ₹12-15 Cr (from ₹70-80 Cr); subsidiary cash break-even FY28 at ~₹120 Cr revenue.
Risks
US HPMC demand absent; API cash burn needs fresh equity; FY29 clawback targets extended informally.
Last quarter's promises, checked
Partly delivered
- FY27 total debt ₹100-110 Cr → gross debt ₹115.91 Cr at 30 Sep, above range; repayments ₹10-12 Cr/yr not reported (= PARTIAL)
Missed
- FY27 API revenue ₹70 Cr (domestic) → guidance cut to ₹12-15 Cr (= MISS)
- FY27 HPMC revenue ₹20 Cr; US line 'expected H2 FY27' → US demand absent, HPMC guidance dropped (= MISS)
- WHO GMP certificate Q2 FY27 → audit delayed (= MISS)
Summary by ALFA Finder, written with AI assistance from the earnings call transcript the company filed, published . Open it on ALFA Filings ›
The results behind this call
Natural Capsules Q2 FY27 Results: Net Loss of ₹4.2 Cr, Loss Narrows
Natural Capsules Ltd reported revenue from operations of ₹51.1 Cr (+11.6% YoY) and a net loss of ₹4.2 Cr for Q2 FY27.
- Key figure
- Net loss ₹4.2 Cr
What management said last time
Full summary →From the call summary published .
Outlook they gave
FY27 revenue guidance ₹274cr; target for USFDA approval within 24 months; ₹25-30cr capex planned for clean rooms.
Growth they described
FY26 revenue ₹187.20cr vs ₹169.21cr FY25. Q4 EBITDA recovered to ₹1.33cr (2.28% margin).
Call details
| Company | Natural Capsules Ltd |
|---|---|
| NSE symbol | NATCAPSUQ |
| ISIN | INE936B01015 |
| Call | Q2 FY27 earnings call |
| Date | Thursday, 19 November 2026 |
| Time | 11:00 AM IST |
| Length | 56 min |
Natural Capsules Ltd: key numbers
- Share price
- ₹126.19
- Market cap
- ₹131.4 Cr
- Revenue (annual)
- ₹187.2 Cr
- Net profit (annual)
- ₹-24.66 Cr
- P/E (TTM)
- -8.3×Sector 49.0×
- Promoter holding
- 50.92%+0.00% QoQ
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.